WO1999033437A1 - Tooth cleaning composition in tablet form - Google Patents

Tooth cleaning composition in tablet form Download PDF

Info

Publication number
WO1999033437A1
WO1999033437A1 PCT/US1997/024121 US9724121W WO9933437A1 WO 1999033437 A1 WO1999033437 A1 WO 1999033437A1 US 9724121 W US9724121 W US 9724121W WO 9933437 A1 WO9933437 A1 WO 9933437A1
Authority
WO
WIPO (PCT)
Prior art keywords
agent
tablet
toothpaste
present
tableting
Prior art date
Application number
PCT/US1997/024121
Other languages
French (fr)
Inventor
Ashok Premchand Luhadiya
Vikram Goel
Stanislaus Valerain D'souza
Original Assignee
The Procter & Gamble Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Procter & Gamble Company filed Critical The Procter & Gamble Company
Priority to AU57257/98A priority Critical patent/AU5725798A/en
Priority to PCT/US1997/024121 priority patent/WO1999033437A1/en
Publication of WO1999033437A1 publication Critical patent/WO1999033437A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms

Definitions

  • the present invention relates generally to a tooth cleaning composition. More particularly, the present invention relates to a tooth cleaning composition in tablet form comprising a polishing agent in combination with a tableting carrier.
  • a satisfactory dentifrice composition should clean and remove debris, thereby aiding the prevention of tooth decay and promoting gingival health.
  • cleaning agents such as abrasives, polishing aids and therapeutic aids.
  • the purpose of the use of these agents is to aid in removal of the film that tends to tightly adhere to the tooth enamel within minutes after eating and which, in many persons, contains pigments which color it brown or yellow.
  • Common practices to clean the teeth include "brushing" the teeth by applying cleaning products.
  • cleaning products There are various types or forms of cleaning products available, for example, pastes, gels, powders, and tablets.
  • the paste form is a common and popular form as a tooth cleaning product and generally is provided by filling laminate tubes with the paste. However, depending on the viscosity of the paste, which is generally high, it may be difficult to squeeze the last drop of the toothpaste from the tube sufficiently. The tubes may further tend to dent during the packing process or during shipment.
  • Tablet is a typical product form seen in various industries, especially in pharmaceuticals, because of the associated ease of manufacturing and handling, e.g., storing, carrying in bags, or using. Consumers often prefer to use tooth cleaning products which are easy to handle when traveling or paticipating in outdoor activities such as camping, sometimes more preferably without brushing. In addition, the convenience of tablets and the fact that water may not be necessary for their use may be desirable in other situations.
  • a variety of approaches for making toothpaste products in tablet form have been developed. See Aberg U.S. Patents 4,753,792 and 5,057,305 disclosing a tooth cleaning tablet that requires chewing the tablet.
  • tooth cleaning compostion in tablet form contain lower levels of water than those in conventional paste form. Due to such lower concentration of water, it is believed that the stability of the tablet products in view of microbial growth, drying out, liquid separation, discoloration, and the like, is improved.
  • the present invention is directed to a toothpaste tablet comprising: (a) from about 20 to about 80 % of a polishing agent; (b) from about 0.2 to about 5.5 % of a thickening agent; and (c) from about 30 to about 80 % of a tableting carrier.
  • the present invention relates to a toothpaste tablet comprising: (a) from about 20 to about 80 % of a polishing agent; (b) from about 0.2 to about 5.5 % of a thickening agent; and (c) from about 30 to about 80 % of a tableting carrier.
  • the tablet of the present invention provides desirable dissolution and disintegration of the tablet in a liquid form rapidly in the mouth when contacted with saliva, water, or both.
  • the dissolved form of the tablet of the present invention is preferably characterized by a thick form such as a paste like form, and can be used to clean the teeth without brushing, for example, by distributing the dissolved tablet around the inside of the mouth, such as by moving the tongue over the surface of the teeth or by swirling throughout the mouth.
  • the tablets can also provide better cost effectiveness for manufacturing and shipment than those in paste form, which tend to dent or deform as a result of having been packed into laminate tubes.
  • the tablet of the present invention further provides improved stability of the products due to containing low levels of water.
  • the tooth cleaning compostion in tablet form of the present invention includes a polishing agent.
  • the polishing agent generally tends for remove debris and reduce tooth decay.
  • the polishing agent of the present invention can be any material which cleans the teeth, removes debris, and/or remove the adhering layers of bacterial film without excessively abrading dentine from the teeth.
  • silicas including gels and precipitates, calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium polymetaphosphate, hydrated alumina, and resinous polishing materials such as particulate condensation products of urea and formaldehyde, and other such as disclosed by Cooley et al. U.S. Patent 3,070,510, incorporated herein by reference.
  • silica polishing agents provide the unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentine.
  • Silica polishing agents are exceptionally compatible with sources of soluble fluoride and polyphosphonates. For these reasons they are preferred for use herein.
  • the silica polishing agents useful herein which can be used alone or in combination with other polishing agents, generally have an average particle size ranging from between about 0.1 to about 30 microns, preferably between about 5 and about 15 microns.
  • the silica polishing agent can be precipitated silica or silica gels such as the silica xerogels described in Pader et al. U.S. Patent
  • the amount of polishing agent herein is present at a level of from about 20% to about 80%, preferably from about 35% to about 70%.
  • the tooth cleaning composition in tablet form of the present invention also includes a thickening agent. These agents can provide a desirable consistency when the toothpaste tablet of the present invention is dissolved in the mouth.
  • Nonlimiting examples of the thickening agents herein include, pregelatinized starch, gums such as agars, locust bean gums, guar gums, and tara gums, carrageenan, alginate, xanthan, dextran, cellulose derivatives such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, gum arabic, and gum tragacanth can also be used. Synthetic silicates such as colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture.
  • the thickening agent is preferably present from about 0.2% to about 5.5% by weight of the total composition.
  • the toothpaste tablet of the present invention includes a tableting carrier.
  • Tabletting carrier means a material which is used for making tablets that provide desirable dissolution and disintegration in the mouth.
  • the tableting carrier is selected depending upon its compatibility with the other ingredients, especially the polishing agent, and the desired characteristic of the product.
  • the tableting carrier is present at an effective level, preferably at a level of from about 20% to about 80%, more preferably from about 38% to about 65% by weight.
  • the tableting carriers useful herein include those selected from the group consisting of sugar, sugar alcohols, and mixtures thereof.
  • sugars useful herein include lactose, glucose, maltodextrins, and sucrose.
  • Sugar alcohols useful herein include sorbitol, xylitol, mannitol and maltitol.
  • the tableting carrier herein is sugar alcohol in combination with lower level of sugar, preferably from about 5 to about 50 % of sugar and from about 5 to about 60 % of sugar alcohol.
  • a preferred combination of the tableting carriers in the present invention is mannitol with a lower level of sucrose.
  • the tableting carrier of the present invention may further include a binding agent, if needed.
  • a binding agent such as mannitol
  • the levels and types of binding agent are selected depending upon the character of the carriers, compatibility with other components, and desired characteristic of the final product.
  • some tableting carriers of the present invention may also have properties as a binding agent for making tablets.
  • tableting carriers herein preferably sugar
  • useful binding agents other than those described as tableting carriers above include starches such as starch paste and pregelatinized starch, polyvinylpyrrolidone, cellulose derivatives, gelatin, gums, and mixtures thereof.
  • the binding agent and the tableting carrier may be made of the same material. Alternatively, the binding agent and the tableting carrier may be altogether different.
  • the binding agents may be present in an effective amount, preferably from about 0.1% to about 5% by weight, more preferably from about 0.5% to about 3%.
  • the toothpaste tablet of the present invention can further include one or more therapeutic agents as dental actives.
  • “Therapeutic agents” herein means agents for prevention and treatment of dental caries or periodontal diseases of the soft tissues of the oral cavity.
  • the therapeutic agents useful for the present invention are selected from the group consisting of an anticaries agent, an anticalculus agent, an antimicrobial agent, an anti-inflammatory agent, and mixtures thereof.
  • anticaries agents as therapeutic agents herein include, but are not limited to, a water-soluble fluoride ion source.
  • the number of such fluoride ion sources is great, and see Norris et al. U.S. Patent 2,946,735, Briner & Widder U.S. Patent 3,535,421 , and Widder et al. U.S. Patent 3,678,154, all of which are incorporated herein by reference.
  • Preferred fluoride ion source materials include: sodium fluoride, potassium fluoride, indium fluoride, stannous fluoride, and sodium monofluorophosphate and mixtures thereof.
  • Sodium fluoride is the preferred fluoride ion source.
  • the amount of the fluoride ion source in the compositions of the present invention, if present, is preferably sufficient to provide from about 0.005% to about 0.35%, more preferably from about 0.05% to about 0.3% of fluoride ions in the compositions.
  • the toothpaste tablet of the present invention can include one or more anticalculus agents as the therapeutic agent, on the condition that they are compatible with the other components of the toothpaste tablets.
  • Anticalculus agents which may be useful herein include, but are not limited to, diphosphonates such as 1 -azocycloheptane-2,2-diphosphonate (AHP) and ethane-1-hydroxy-1 ,1-diphosphonate (EHDP), sodium zinc citrate, phosphocitrate, tripolyphosphate, and linear polycarboxylate (LPC); pyrophosphates or polyphosphates, see Parran & Sakkab U.S. Patent 4,590,066 (e.g.
  • tetrasodium pyrophosphate tetrapotassium pyrophosphate, and dihydrogen disodium pyrophosphate
  • polyacrylates and other polycarboxylates see Shedlovsky U.S. Patent 3,429,963, and Chang U.S. Patent 4,304,766; and Benedict & Sunberg U.S. Patent 4,661 ,341 ; polyepoxysuccinates, see Benedict U.S. Patent 4,846,650; ethylenediaminetetraacetic acid, see British Patent No. 490,384; nitrilotriacetic acid and related compounds, see Widder & Briner U.S. Patent 3,678,154; polyphosphonates see Francis U.S.
  • the anticalculus agents generally comprise from about 0.2% to about 13%, preferably from about 0.4% to about 6%, of the compositions of the present invention.
  • Preferred anticalculus agents are pyrophosphates.
  • Antimicrobial agents include compounds which can be employed as antiplaque agents and antibacterial agents. Antimicrobial agents herein can be present in the toothpaste tablet on the condition that they are compatible with the other ingredients and/or compounds included. Such agents may be noncationic and substantially water insoluble; that is, solubility is less than about 1% by weight in water at 25°C. Nonlimiting examples of the antimicrobial agents herein include triclosan, 2,4,4'- trichloro-2'-hydroxydiphenyl ether, as described The Merck Index, 11th Ed. (1989), p. 1520 (entry No. 9573); in U.S. Pat. No.
  • TPC tetradecylpyridinium chloride
  • TDEPC N- tetradecyl-4-ethylpyridinium chloride
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • octapinol octapinol, and other piperidino derivatives
  • octenidine delmopinol, octapinol, and other piperidino derivatives
  • octapinol octapinol, and other piperidino derivatives
  • octenidine de
  • stannous salts such as stannous pyrophosphate and stannous gluconate and antimicrobials such as quaternary ammonium salts, such as cetyl pyridinium chloride and tetradecylethyl pyridinium chloride, bis-biquanide salts, copper bisglycinate, nonionic anti microbial salts and flavor oils.
  • antimicrobial agents may comprise from about 0.01% to about 6%, preferably from about 0.1% to about 5% by weight of the compositions of the present invention.
  • anti-inflammatory agents include herein, but are not limited to, aspirin, acetaminophen, ibuprofen, naproxen, indomethacin, piroxicam, meclofenamate sodium, tenidap, tebufelone, benoxaprofen, flurbiprofen, ketoprofen, ketorolac, etodolac, fenoprofen, fenbufen, indoprofen, pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen, tiaprofen, their pharmaceutically-acceptable salts, and mixtures thereof.
  • the typical concentrations of anti-inflammatory agents in the dental compositions of the present invention are from about 0.004% to about 20%, preferably from about 0.02% to about 4%, more preferably from about 0.04% to about 2%, and most preferably from about 0.2% to about 0.8% of the compositions of the present invention.
  • the toothpaste tablet of the present invention may further include an oral carriers.
  • Oral carrier means one or more compatible solid or liquid substances which are suitable for oral administration to a human.
  • the oral carriers must be of sufficiently high purity and sufficiently low toxicity to render them suitable for administration to human beings.
  • the oral carrier herein include a surfactant, an effervescent agent, a humectant, a tableting aid, a sweetening agent, a flavoring agent, a coloring agent, a preservative, a cooling agent, a buffering agent, and mixtures thereof.
  • Surfactant The toothpaste tablet of the present invention may include a surfactant as the oral carrier.
  • Surfactants used for emulsif ⁇ cation herein are those which are reasonably stable and foam throughout a wide pH range.
  • the surfactants useful herein include anionic surfactants; nonionic surfactants produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic such as aliphatics or alkylaromatics in nature; cationic such as aliphatic quaternary ammonium compounds having one long alkyl chain containing from about 8 to 18 carbons; and zwitterionic and amphoteric synthetic surfactants such as derivatives of aliphatic quaternary ammonium, phos- phomium, and sulfonium compounds, preferably those sodium and potassium salts.
  • Preferred surfactants useful herein are anionic surfactants including the water-soluble salts, sodium or potassium salts of alkyl sulfates having from 10 to 18 carbon atoms in the alkyl radical and sulfonated monoglycerides of fatty acids having from 10 to 18 carbons.
  • Sodium lauryl sulfate and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of this type. Mixtures of anionic surfactants can also be utilized.
  • Betaine surfactants can also be used for the composition of the present invention.
  • the betaine surfactants herein include alkyl dimethyl betaines include decyl betaine or 2-(N-decyl-N,N-dimethylammonio) acetate, coco betaine or 2-(N- coc-N, N-dimethyl ammonio) acetate, myristyl betaine, palmityl betaine, lauryl betaine, cetyl betaine, stearyl betaine, etc.
  • the amidobetaines are exemplified by cocoamidoethyl betaine, cocoamidopropyl betaine, lauramidopropyl betaine and the like.
  • the betaines of choice are preferably the cocoamidopropyl betaine and, more preferably, the lauramido propel betaine. See Polefka et al. U.S. Patent 5,180,577.
  • the surfactants are generally used at levels of from about 0.035% to about 7.0% by weight. 2. Effervescent agent
  • the toothpaste tablet of the present invention may include an effervescent agent to provide bubbles which are sometimes desired for aesthetic purposes.
  • "Effervescent agent” herein means a material that provides effervescence by the reaction of a carbonate source with an acidic source, for example, in the combination of a carbonate salt and a carboxylic acid. Any ingredients which would be useful conventionally as an effervescence agent in the pharmaceutical area may be acceptable herein.
  • the carbonate sources herein include calcium carbonate, sodium carbonate, and sodium bicarbonate.
  • Preferred acid sources useful herein include a citric acid, and a malic acid.
  • the effervescent agent may be present at levels of from about 0.5 to about 20% by weight.
  • humectant material in the toothpaste tablet of the present invention to keep it from hardening upon exposure to air and to give the tablet a moist feel to the mouth.
  • Suitable humectants include polyethylene glycol, sorbitol, xylitol, other edible polyhydric alcohols, and mixtures thereof, at a level of from about 0% to about 70%, preferably from about 2% to about 55%, by weight.
  • Tableting aids can be added in order to facilitate forming the toothpaste tablets.
  • tablettes refers to an ingredient that is generally added to the granules in small quantities, to provide flowability to the granules, to reduce friction, and/or to ease removal of the tablets from the tableting machine.
  • the tableting aids useful herein include, for example, magnesium stearate, stearic acid, aerosol, talc, and mixtures thereof.
  • the tableting aid of the compositions of the present invention is preferably present in an amount sufficient to prevent the tablet from sticking to the machine and improve flow characteristic of the compression mixture.
  • the tabelting aids are present at levels from about 2% to about 8%. 5.
  • Sweetening agents can be added to the present compositions. These include aspartame, acesulfame, sodium saccharin, dextrose, sucrose, lactose, maltose, xylitol, levulose, thaumatin, dihydrochalcones, sodium cyclamate and mixtures thereof. Sweetening agents are generally useful herein the toothpaste tablet at levels of from about 0.05% to about 2%. 6. Flavoring agents
  • Flavoring agents can also be added to the toothpaste tablet of the present invention.
  • flavoring agents useful in the present invention include oil of peppermint, oil of sassafras, clove bud oil, peppermint, menthol, anethole, thymol, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, oil of wintergreen, alpha-irisone, oil of spearmint, marjoram, lemon, orange, propenyl guaethol, cinnamon, and mixtures thereof.
  • Flavoring agents are generally used in the toothpaste tablet at levels of from about 0.01% to about 5% by weight of the composition. 7. Coloring agent
  • the composition may further include a coloring agent. Titanium dioxide which is a white pigment in powder form may also be added.
  • the coloring agent including titanium dioxide may be present at an effective level from about 0.025% to about 1%. 8. Preservatives
  • preservatives prevent microbial growth in the compositions.
  • Suitable preservatives include methylparaben, propylparaben, and benzoates.
  • the preservatives generally comprise from about 0% to about 5%, preferably from about 0.1% to about 2%.
  • Suitable cooling agents are those described in Watson et al. U.S. Patent 4,136,163, Rowsell et al. U.S. Patents 4,032,661 and 4,230,688, and Grub et al. U.S. Patent 5,266,592, all of which are herein incorporated by reference.
  • Particularly preferred cooling agents include N-ethyl-p-menthane-3-carboxamide outlined by the above incorporated U.S. Patent 4,136,163 and N,2,3-trimethyl-2- isopropylbutanamide which is stated by the above incorporated U.S. Patent 4,230,688.
  • Another particularly preferred cooling agent is 3-1-menthoxypropane 1 ,2-diol. See Amano et al. U.S. Patent 4,459,425.
  • the cooling agent generally comprise from about 0% to about 5%, preferably from about 0.1 % to about 2%.
  • the toothpaste tablet herein may also include a buffering agent.
  • Buffering agents refer to agents that can be used to adjust the pH of the compositions to a range of about pH 7 to about pH 9. These agents include mono and trisodium phosphate, sodium carbonate, tris(hydroxymethyl)aminomethane, tetra and disodium pyrophosphate and tetrapotassium pyrophosphate, at a level of from about 0.5% to about 10%.
  • the resulting toothpaste tablets dissolve and/or disintegrate smoothly when contacted with saliva, water, or both and produce little to no gritty sensation in the user's mouth.
  • the toothpaste tablets of the present invention can be produced by any method useful for forming conventional tablets known in the art. These conventional methods include granulating methods: either wet or dry granulating method, preferably wet granulating. Depending on the properties of the ingredients (e.g., polishing agents, tableting carriers, flavors, coloring agents, and the like) to be formulated into granules, one method may provide a more favorable end product over the other method.
  • the wet granulation method is widely used and usually produces the most satisfactory results in tablets. See E.J. de Jong; "The preparation of microgranulates, an improved tableting technique," Pharmaceutical Weekblad, 104(23), pages 469-474, 1969 and E.J. de Jong, U.S. Patent 3,266,992. Direct compression without granulation step may also be chosen for the present composition, as long as producing non-gritty tablets does not cause capping.
  • a method for making a toothpaste tablet of the present invention comprises:
  • polishing agents and tableting carriers such as sugar, sugar alcohol, and any of oral carriers (e.g., coloring agent), if needed, to make granules;
  • step (4) mixing the granules of step (4) with oral carriers other than those of step(1) (e.g., thickening agent, sweetening agent, flavour, tableting aids); and
  • step (6) compressing the mixture of step (5) to form tablets by conventional method.
  • the toothpaste tablets of the present invention can be used to clean the teeth by:
  • the embodiments disclosed and represented by the present examples have many advantages. For example, they can provide improved dissolution and disintegration properties of tablet in a liquid form rapidly in the mouth when contacted with saliva, water, or both without the need to chew the tablet or use a brush to effect cleaning of the teeth.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

A toothpaste tablet is disclosed, comprising: (a) from about 20 to about 80 % of a polishing agent; (b) from about 0.2 to about 5.5 % of a thickening agent; and (c) from about 30 to about 80 % of a tableting carrier.

Description

TOOTH CLEANING COMPOSITION IN TABLET FORM
FIELD
The present invention relates generally to a tooth cleaning composition. More particularly, the present invention relates to a tooth cleaning composition in tablet form comprising a polishing agent in combination with a tableting carrier.
BACKGROUND
A satisfactory dentifrice composition should clean and remove debris, thereby aiding the prevention of tooth decay and promoting gingival health. In order to achieve these ends, it is necessary to brush with a dentifrice containing cleaning agents such as abrasives, polishing aids and therapeutic aids. The purpose of the use of these agents is to aid in removal of the film that tends to tightly adhere to the tooth enamel within minutes after eating and which, in many persons, contains pigments which color it brown or yellow. Common practices to clean the teeth include "brushing" the teeth by applying cleaning products. There are various types or forms of cleaning products available, for example, pastes, gels, powders, and tablets. The paste form is a common and popular form as a tooth cleaning product and generally is provided by filling laminate tubes with the paste. However, depending on the viscosity of the paste, which is generally high, it may be difficult to squeeze the last drop of the toothpaste from the tube sufficiently. The tubes may further tend to dent during the packing process or during shipment.
Tablet is a typical product form seen in various industries, especially in pharmaceuticals, because of the associated ease of manufacturing and handling, e.g., storing, carrying in bags, or using. Consumers often prefer to use tooth cleaning products which are easy to handle when traveling or paticipating in outdoor activities such as camping, sometimes more preferably without brushing. In addition, the convenience of tablets and the fact that water may not be necessary for their use may be desirable in other situations. A variety of approaches for making toothpaste products in tablet form have been developed. See Aberg U.S. Patents 4,753,792 and 5,057,305 disclosing a tooth cleaning tablet that requires chewing the tablet. In general, tooth cleaning compostion in tablet form contain lower levels of water than those in conventional paste form. Due to such lower concentration of water, it is believed that the stability of the tablet products in view of microbial growth, drying out, liquid separation, discoloration, and the like, is improved.
Based on the foregoing, there is a need for a toothpaste tablet having improved dissolution and disintegration properties of tablet in a liquid form rapidly in the mouth when contacted with saliva, water, or both without the need to chew the tablet or use a brush to effect cleaning of the teeth. None of the existing art provides all of the advantages and benefits of the present invention.
SUMMARY The present invention is directed to a toothpaste tablet comprising: (a) from about 20 to about 80 % of a polishing agent; (b) from about 0.2 to about 5.5 % of a thickening agent; and (c) from about 30 to about 80 % of a tableting carrier.
These and other features, aspects, and advantages of the present invention will become better understood from a reading of the following description, and appended claims.
DETAILED DESCRIPTION
While the specification concludes with claims particularly pointing out and distinctly claiming the invention, it is believed that the present invention will be better understood from the following description.
All percentages and ratios used hereinafter are by weight of total composition, unless otherwise indicated.
All measurements referred to herein are made at 25°C unless otherwise specified.
All percentages, ratios, and levels of ingredients referred to herein are based on the actual amount of the ingredient, and do not include solvents, fillers, or other materials with which the ingredient may be combined as a commercially available product, unless otherwise indicated. All publications, patent applications, and issued patents mentioned herein are hereby incorporated in their entirety by reference. Citation of any reference is not an admission regarding any determination as to its availability as prior art to the claimed invention. "Comprising" means that other steps and other components which do not affect the end result can be added. This term encompasses the terms "consisting of and "consisting essentially of."
The present invention relates to a toothpaste tablet comprising: (a) from about 20 to about 80 % of a polishing agent; (b) from about 0.2 to about 5.5 % of a thickening agent; and (c) from about 30 to about 80 % of a tableting carrier. The tablet of the present invention provides desirable dissolution and disintegration of the tablet in a liquid form rapidly in the mouth when contacted with saliva, water, or both. The dissolved form of the tablet of the present invention is preferably characterized by a thick form such as a paste like form, and can be used to clean the teeth without brushing, for example, by distributing the dissolved tablet around the inside of the mouth, such as by moving the tongue over the surface of the teeth or by swirling throughout the mouth. The tablets can also provide better cost effectiveness for manufacturing and shipment than those in paste form, which tend to dent or deform as a result of having been packed into laminate tubes. The tablet of the present invention further provides improved stability of the products due to containing low levels of water.
A. Polishing agent The tooth cleaning compostion in tablet form of the present invention includes a polishing agent. The polishing agent generally tends for remove debris and reduce tooth decay. The polishing agent of the present invention can be any material which cleans the teeth, removes debris, and/or remove the adhering layers of bacterial film without excessively abrading dentine from the teeth. These include, for example, silicas, including gels and precipitates, calcium carbonate, dicalcium orthophosphate dihydrate, calcium pyrophosphate, tricalcium phosphate, calcium polymetaphosphate, insoluble sodium polymetaphosphate, hydrated alumina, and resinous polishing materials such as particulate condensation products of urea and formaldehyde, and other such as disclosed by Cooley et al. U.S. Patent 3,070,510, incorporated herein by reference.
Various silica polishing agents provide the unique benefits of exceptional dental cleaning and polishing performance without unduly abrading tooth enamel or dentine. Silica polishing agents are exceptionally compatible with sources of soluble fluoride and polyphosphonates. For these reasons they are preferred for use herein.
The silica polishing agents useful herein, which can be used alone or in combination with other polishing agents, generally have an average particle size ranging from between about 0.1 to about 30 microns, preferably between about 5 and about 15 microns. The silica polishing agent can be precipitated silica or silica gels such as the silica xerogels described in Pader et al. U.S. Patent
3,538,230, and DiGiulio U.S. Patent 3,862,307 both incorporated herein by reference. Preferred are the silica xerogels marketed under the tradename "Syloid" by the W. R. Grace & Company, Davison Chemical Division. Preferred precipitated silicas include those marketed by the J. M. Huber Corporation under the tradename, "Zeodent", particularly the silica polishing agent carrying the designation "Zeodent 119". These silica polishing agents are described in U.S.
Patent No. 4,340,583, incorporated herein by reference. Mixtures of these polishing agents may also be used. The amount of polishing agent herein is present at a level of from about 20% to about 80%, preferably from about 35% to about 70%.
B. Thickening agent The tooth cleaning composition in tablet form of the present invention also includes a thickening agent. These agents can provide a desirable consistency when the toothpaste tablet of the present invention is dissolved in the mouth. Nonlimiting examples of the thickening agents herein include, pregelatinized starch, gums such as agars, locust bean gums, guar gums, and tara gums, carrageenan, alginate, xanthan, dextran, cellulose derivatives such as sodium carboxymethyl cellulose and sodium carboxymethyl hydroxyethyl cellulose. Natural gums such as gum karaya, gum arabic, and gum tragacanth can also be used. Synthetic silicates such as colloidal magnesium aluminum silicate or finely divided silica can be used as part of the thickening agent to further improve texture. The thickening agent is preferably present from about 0.2% to about 5.5% by weight of the total composition.
C. Tableting carrier The toothpaste tablet of the present invention includes a tableting carrier.
"Tableting carrier", as used herein, means a material which is used for making tablets that provide desirable dissolution and disintegration in the mouth. The tableting carrier is selected depending upon its compatibility with the other ingredients, especially the polishing agent, and the desired characteristic of the product. The tableting carrier is present at an effective level, preferably at a level of from about 20% to about 80%, more preferably from about 38% to about 65% by weight.
The tableting carriers useful herein include those selected from the group consisting of sugar, sugar alcohols, and mixtures thereof. Nonlimiting examples of sugars useful herein include lactose, glucose, maltodextrins, and sucrose. Sugar alcohols useful herein include sorbitol, xylitol, mannitol and maltitol. Preferably, the tableting carrier herein is sugar alcohol in combination with lower level of sugar, preferably from about 5 to about 50 % of sugar and from about 5 to about 60 % of sugar alcohol. A preferred combination of the tableting carriers in the present invention is mannitol with a lower level of sucrose.
The tableting carrier of the present invention may further include a binding agent, if needed. Inclusion of the binding agent is particularly useful when a tableting carrier, such as mannitol, may have a limited ability to bind the components used for the composition. It is believed that insufficiencies in binding ability tend to cause tablets to break off into two pieces along the length during the manufacturing process. This splitting of the tablet is commonly referred to as "capping." The levels and types of binding agent are selected depending upon the character of the carriers, compatibility with other components, and desired characteristic of the final product. In addition, it is recognized that some tableting carriers of the present invention may also have properties as a binding agent for making tablets. Most of tableting carriers herein, preferably sugar, may be useful for providing improved binding properties of the toothpaste tablet to prevent the tablet from breaking into two pieces. Examples of useful binding agents other than those described as tableting carriers above include starches such as starch paste and pregelatinized starch, polyvinylpyrrolidone, cellulose derivatives, gelatin, gums, and mixtures thereof. In certain embodiments, the binding agent and the tableting carrier may be made of the same material. Alternatively, the binding agent and the tableting carrier may be altogether different.
The binding agents may be present in an effective amount, preferably from about 0.1% to about 5% by weight, more preferably from about 0.5% to about 3%.
D. Therapeutic agent
The toothpaste tablet of the present invention can further include one or more therapeutic agents as dental actives. "Therapeutic agents" herein means agents for prevention and treatment of dental caries or periodontal diseases of the soft tissues of the oral cavity. The therapeutic agents useful for the present invention are selected from the group consisting of an anticaries agent, an anticalculus agent, an antimicrobial agent, an anti-inflammatory agent, and mixtures thereof.
1. Anticaries agent Typical examples of anticaries agents as therapeutic agents herein include, but are not limited to, a water-soluble fluoride ion source. The number of such fluoride ion sources is great, and see Norris et al. U.S. Patent 2,946,735, Briner & Widder U.S. Patent 3,535,421 , and Widder et al. U.S. Patent 3,678,154, all of which are incorporated herein by reference. Preferred fluoride ion source materials include: sodium fluoride, potassium fluoride, indium fluoride, stannous fluoride, and sodium monofluorophosphate and mixtures thereof. Sodium fluoride is the preferred fluoride ion source. The amount of the fluoride ion source in the compositions of the present invention, if present, is preferably sufficient to provide from about 0.005% to about 0.35%, more preferably from about 0.05% to about 0.3% of fluoride ions in the compositions.
2. Anticalculus agent
The toothpaste tablet of the present invention can include one or more anticalculus agents as the therapeutic agent, on the condition that they are compatible with the other components of the toothpaste tablets. Anticalculus agents which may be useful herein include, but are not limited to, diphosphonates such as 1 -azocycloheptane-2,2-diphosphonate (AHP) and ethane-1-hydroxy-1 ,1-diphosphonate (EHDP), sodium zinc citrate, phosphocitrate, tripolyphosphate, and linear polycarboxylate (LPC); pyrophosphates or polyphosphates, see Parran & Sakkab U.S. Patent 4,590,066 (e.g. tetrasodium pyrophosphate, tetrapotassium pyrophosphate, and dihydrogen disodium pyrophosphate); polyacrylates and other polycarboxylates, see Shedlovsky U.S. Patent 3,429,963, and Chang U.S. Patent 4,304,766; and Benedict & Sunberg U.S. Patent 4,661 ,341 ; polyepoxysuccinates, see Benedict U.S. Patent 4,846,650; ethylenediaminetetraacetic acid, see British Patent No. 490,384; nitrilotriacetic acid and related compounds, see Widder & Briner U.S. Patent 3,678,154; polyphosphonates see Francis U.S. Patent 3,737,533, Ploger U.S. Patent 3,988,443, and Degenhardt & Kozikowski U.S. Patent 4,877,603; all of these patents are incorporated herein by reference. If present, the anticalculus agents generally comprise from about 0.2% to about 13%, preferably from about 0.4% to about 6%, of the compositions of the present invention. Preferred anticalculus agents are pyrophosphates.
3. Antimicrobial agent "Antimicrobial agents", as used herein, include compounds which can be employed as antiplaque agents and antibacterial agents. Antimicrobial agents herein can be present in the toothpaste tablet on the condition that they are compatible with the other ingredients and/or compounds included. Such agents may be noncationic and substantially water insoluble; that is, solubility is less than about 1% by weight in water at 25°C. Nonlimiting examples of the antimicrobial agents herein include triclosan, 2,4,4'- trichloro-2'-hydroxydiphenyl ether, as described The Merck Index, 11th Ed. (1989), p. 1520 (entry No. 9573); in U.S. Pat. No. 3,506,720; and in Europe Patent Application number 0,251,591 of Beecham Group, PLC, published Jan. 7, 1988, chlorhexidine, (Merck Index., No. 2090), alexidine (Meek Index, No. 222); hexetidine (Merck Index, No. 4624); sanguinarine (Merck Index, No. 8320); benzalkonium chloride (Merck Index, No. 1066); salicylanilide (Merck Index., No. 8299); domiphen bromide (Merck Index, No. 3411); cetylpyridinium chloride, (CPC) (Merck Index, No. 2024); tetradecylpyridinium chloride, (TPC); N- tetradecyl-4-ethylpyridinium chloride (TDEPC); octenidine; delmopinol, octapinol, and other piperidino derivatives; nicin preparations; zinc/stannous ion agents; antibiotics such as augmentin, amoxicillin, tetracycline, doxycycline, minocycline, and metronidazole; and peroxides, such as cylium peroxide, hydrogen peroxide, and magnesium monoperthalate and its analog, see Sampathkumar U.S. Patent 4,670,252; and analogs and salts of the above antimicrobial agents.
Also desirable for inclusion herein are stannous salts such as stannous pyrophosphate and stannous gluconate and antimicrobials such as quaternary ammonium salts, such as cetyl pyridinium chloride and tetradecylethyl pyridinium chloride, bis-biquanide salts, copper bisglycinate, nonionic anti microbial salts and flavor oils. See Norris et al. U.S. Patent 2,946,725 and Gieske et al. U.S. Patent 4,051 ,234. If present, the antimicrobial agents may comprise from about 0.01% to about 6%, preferably from about 0.1% to about 5% by weight of the compositions of the present invention.
4.Anti-inflammatory agents Typical examples of the anti-inflammatory agents include herein, but are not limited to, aspirin, acetaminophen, ibuprofen, naproxen, indomethacin, piroxicam, meclofenamate sodium, tenidap, tebufelone, benoxaprofen, flurbiprofen, ketoprofen, ketorolac, etodolac, fenoprofen, fenbufen, indoprofen, pirprofen, carprofen, oxaprozin, pranoprofen, miroprofen, tioxaprofen, suprofen, alminoprofen, tiaprofen, their pharmaceutically-acceptable salts, and mixtures thereof. The typical concentrations of anti-inflammatory agents in the dental compositions of the present invention are from about 0.004% to about 20%, preferably from about 0.02% to about 4%, more preferably from about 0.04% to about 2%, and most preferably from about 0.2% to about 0.8% of the compositions of the present invention.
E. Oral carrier
The toothpaste tablet of the present invention may further include an oral carriers. "Oral carrier", as used herein, means one or more compatible solid or liquid substances which are suitable for oral administration to a human. The oral carriers must be of sufficiently high purity and sufficiently low toxicity to render them suitable for administration to human beings. The oral carrier herein include a surfactant, an effervescent agent, a humectant, a tableting aid, a sweetening agent, a flavoring agent, a coloring agent, a preservative, a cooling agent, a buffering agent, and mixtures thereof. 1. Surfactant The toothpaste tablet of the present invention may include a surfactant as the oral carrier. Surfactants used for emulsifϊcation herein are those which are reasonably stable and foam throughout a wide pH range. The surfactants useful herein include anionic surfactants; nonionic surfactants produced by the condensation of alkylene oxide groups (hydrophilic in nature) with an organic hydrophobic such as aliphatics or alkylaromatics in nature; cationic such as aliphatic quaternary ammonium compounds having one long alkyl chain containing from about 8 to 18 carbons; and zwitterionic and amphoteric synthetic surfactants such as derivatives of aliphatic quaternary ammonium, phos- phomium, and sulfonium compounds, preferably those sodium and potassium salts. See Agricola et al, U.S. Patent 3,959,458, Haefele U.S. Patent 3,937,807, and Gieske et al, U.S. Patent 4,051 ,234, incorporated herein by reference.
Preferred surfactants useful herein are anionic surfactants including the water-soluble salts, sodium or potassium salts of alkyl sulfates having from 10 to 18 carbon atoms in the alkyl radical and sulfonated monoglycerides of fatty acids having from 10 to 18 carbons. Sodium lauryl sulfate and sodium coconut monoglyceride sulfonates are examples of anionic surfactants of this type. Mixtures of anionic surfactants can also be utilized.
Betaine surfactants can also be used for the composition of the present invention. The betaine surfactants herein include alkyl dimethyl betaines include decyl betaine or 2-(N-decyl-N,N-dimethylammonio) acetate, coco betaine or 2-(N- coc-N, N-dimethyl ammonio) acetate, myristyl betaine, palmityl betaine, lauryl betaine, cetyl betaine, stearyl betaine, etc. The amidobetaines are exemplified by cocoamidoethyl betaine, cocoamidopropyl betaine, lauramidopropyl betaine and the like. The betaines of choice are preferably the cocoamidopropyl betaine and, more preferably, the lauramido propel betaine. See Polefka et al. U.S. Patent 5,180,577.
If present, the surfactants are generally used at levels of from about 0.035% to about 7.0% by weight. 2. Effervescent agent
The toothpaste tablet of the present invention may include an effervescent agent to provide bubbles which are sometimes desired for aesthetic purposes. "Effervescent agent" herein means a material that provides effervescence by the reaction of a carbonate source with an acidic source, for example, in the combination of a carbonate salt and a carboxylic acid. Any ingredients which would be useful conventionally as an effervescence agent in the pharmaceutical area may be acceptable herein. Preferably, the carbonate sources herein include calcium carbonate, sodium carbonate, and sodium bicarbonate. Preferred acid sources useful herein include a citric acid, and a malic acid. The effervescent agent may be present at levels of from about 0.5 to about 20% by weight.
3. Humectant
It may also be desirable to include some humectant material in the toothpaste tablet of the present invention to keep it from hardening upon exposure to air and to give the tablet a moist feel to the mouth. Suitable humectants include polyethylene glycol, sorbitol, xylitol, other edible polyhydric alcohols, and mixtures thereof, at a level of from about 0% to about 70%, preferably from about 2% to about 55%, by weight.
4. Tableting aids Tableting aids can be added in order to facilitate forming the toothpaste tablets. Herein, "tableting aids" refers to an ingredient that is generally added to the granules in small quantities, to provide flowability to the granules, to reduce friction, and/or to ease removal of the tablets from the tableting machine. The tableting aids useful herein include, for example, magnesium stearate, stearic acid, aerosol, talc, and mixtures thereof. The tableting aid of the compositions of the present invention, is preferably present in an amount sufficient to prevent the tablet from sticking to the machine and improve flow characteristic of the compression mixture. The tabelting aids are present at levels from about 2% to about 8%. 5. Sweetening agents
Sweetening agents can be added to the present compositions. These include aspartame, acesulfame, sodium saccharin, dextrose, sucrose, lactose, maltose, xylitol, levulose, thaumatin, dihydrochalcones, sodium cyclamate and mixtures thereof. Sweetening agents are generally useful herein the toothpaste tablet at levels of from about 0.05% to about 2%. 6. Flavoring agents
Flavoring agents can also be added to the toothpaste tablet of the present invention. Examples of flavoring agents useful in the present invention include oil of peppermint, oil of sassafras, clove bud oil, peppermint, menthol, anethole, thymol, methyl salicylate, eucalyptol, cassia, 1-menthyl acetate, sage, eugenol, parsley oil, oxanone, oil of wintergreen, alpha-irisone, oil of spearmint, marjoram, lemon, orange, propenyl guaethol, cinnamon, and mixtures thereof. Flavoring agents are generally used in the toothpaste tablet at levels of from about 0.01% to about 5% by weight of the composition. 7. Coloring agent
The composition may further include a coloring agent. Titanium dioxide which is a white pigment in powder form may also be added. The coloring agent including titanium dioxide may be present at an effective level from about 0.025% to about 1%. 8. Preservatives
Other oral carrier of the present invention may included are preservatives. The preservatives prevent microbial growth in the compositions. Suitable preservatives include methylparaben, propylparaben, and benzoates. The preservatives generally comprise from about 0% to about 5%, preferably from about 0.1% to about 2%.
9. Cooling agent
Suitable cooling agents are those described in Watson et al. U.S. Patent 4,136,163, Rowsell et al. U.S. Patents 4,032,661 and 4,230,688, and Grub et al. U.S. Patent 5,266,592, all of which are herein incorporated by reference. Particularly preferred cooling agents include N-ethyl-p-menthane-3-carboxamide outlined by the above incorporated U.S. Patent 4,136,163 and N,2,3-trimethyl-2- isopropylbutanamide which is stated by the above incorporated U.S. Patent 4,230,688. Another particularly preferred cooling agent is 3-1-menthoxypropane 1 ,2-diol. See Amano et al. U.S. Patent 4,459,425. The cooling agent generally comprise from about 0% to about 5%, preferably from about 0.1 % to about 2%.
10. Buffering agent
The toothpaste tablet herein may also include a buffering agent. Buffering agents, as used herein, refer to agents that can be used to adjust the pH of the compositions to a range of about pH 7 to about pH 9. These agents include mono and trisodium phosphate, sodium carbonate, tris(hydroxymethyl)aminomethane, tetra and disodium pyrophosphate and tetrapotassium pyrophosphate, at a level of from about 0.5% to about 10%.
The resulting toothpaste tablets dissolve and/or disintegrate smoothly when contacted with saliva, water, or both and produce little to no gritty sensation in the user's mouth. F. Method of making tablets
The toothpaste tablets of the present invention can be produced by any method useful for forming conventional tablets known in the art. These conventional methods include granulating methods: either wet or dry granulating method, preferably wet granulating. Depending on the properties of the ingredients (e.g., polishing agents, tableting carriers, flavors, coloring agents, and the like) to be formulated into granules, one method may provide a more favorable end product over the other method. The wet granulation method is widely used and usually produces the most satisfactory results in tablets. See E.J. de Jong; "The preparation of microgranulates, an improved tableting technique," Pharmaceutical Weekblad, 104(23), pages 469-474, 1969 and E.J. de Jong, U.S. Patent 3,266,992. Direct compression without granulation step may also be chosen for the present composition, as long as producing non-gritty tablets does not cause capping.
In one embodiment, a method for making a toothpaste tablet of the present invention comprises:
(1) adding polishing agents and tableting carriers such as sugar, sugar alcohol, and any of oral carriers (e.g., coloring agent), if needed, to make granules;
(2) passing the granules through #10 mesh;
(3) drying the sieved granules by conventional drying techniques;
(4) sieving again the dried granules through #14 mesh;
(5) mixing the granules of step (4) with oral carriers other than those of step(1) (e.g., thickening agent, sweetening agent, flavour, tableting aids); and
(6) compressing the mixture of step (5) to form tablets by conventional method.
G. Method of use The toothpaste tablets of the present invention can be used to clean the teeth by:
(1) putting the toothpaste tablet into the mouth;
(2) keeping the toothpaste tablet for a few moments until substantially dissolved, and distributing the dissolved tablet around the inside of the mouth so as to contact the teeth, for example by moving the tongue on to the surface of the teeth to clean them.
EXAMPLES The following examples further describe and demonstrate embodiments within the scope of the present invention. The examples are given solely for the purpose of illustration and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the invention. The components shown below can be prepared by any conventional method known in the art. Suitable methods and formulations are as follows:
EXAMPLE I
The following representative example of a toothpaste tablet composition of the present invention is made by conventional process:
Component %by weight
Mannitol 47.00
Calcium Carbonate 27.00
Pregel Starch 0.50
Aspartame 0.35
FD & C BIue # 1 0.01
Sodium fluoride 0.24
Flavour 1.10
Sodium alkyl sulphate 1.00
Potassium citrate 2.10
Xanthan gum 2.85
Titanium dioxide 0.50
Sodium carboxymethyl cellulose 2.65
Synthetic silicate 0.20
Sucrose 10.00
Magnesium stearate 2.50
Talc 2.00
EXAMPLE II
The following representative example of a toothpaste tablet composition of the present invention is made by conventional process:
Component %by weight Sorbitol 10
Mannitol 46.7
Preciitated Silica 30
Sodium Alkyl Sulphate 1.0
Potassium citrate 1.0 Cetyl Pyridinium chloride 0.32
Sodium Saccharine 0.13
Xanthan gum 0.1
Sodium carboxymethyl cellulose 0.15
Synthetic Silicate 4.6 Flavour 1.5
Magnesium stearate 2.50
Talc 2.00
The embodiments disclosed and represented by the present examples have many advantages. For example, they can provide improved dissolution and disintegration properties of tablet in a liquid form rapidly in the mouth when contacted with saliva, water, or both without the need to chew the tablet or use a brush to effect cleaning of the teeth.
It is understood that the foregoing detailed description of examples and embodiments of the present invention are given merely by way of illustration, and that numerous modifications and variations may become apparent to those skilled in the art without departing from the spirit and scope of the invention; and such apparent modifications and variations are to be included in the scope of the appended claims.

Claims

WHAT IS CLAIMED IS:
1. A toothpaste tablet comprising:
(a) from about 20 to about 80 % of a polishing agent;
(b) from about 0.2 to about 5.5 % of a thickening agent; and
(c) from about 30 to about 80 % of a tableting carrier.
2. The toothpaste tablet of Claim 1 , wherein the tableting carrier is selected from the group consisting of sugar, sugar alcohol, and mixtures thereof.
3. The toothpaste tablet of Claim 2, wherein the toothpaste tablet further comprises a therapeutic agent selected from the group consisting of an anticaries agent, an anticalculus agent, an antimicrobial agent, an anti-inflammatory agent, and mixtures thereof.
4. The toothpaste tablet of Claim 3, wherein the toothpaste tablet further comprises an oral carrier selected from the group consisting of a surfactant, an effervescent agent, a humectant, a tableting aid, a sweetening agent, a flavoring agent, a coloring agent, a preservative, a cooling agent, a buffering agent, and mixtures thereof.
5. The toothpaste tablet of Claim 4, wherein the toothpaste tablet further comprises a effervescent salt derived from a carbonate source and an acidic source.
6. The toothpaste tablet of Claim 2, wherein the tableting carrier comprises:
(a) from about 5 to about 50 % of sugar; and
(b) from about 5 to about 60 % of sugar alcohol.
7. A method for cleaning teeth by putting the toothpaste tablet of Claim 1 into the mouth, wherein the toothpaste tablet is substantially dissolved when contacted with saliva, water, or both.thereby changing the form into liquid.
PCT/US1997/024121 1997-12-29 1997-12-29 Tooth cleaning composition in tablet form WO1999033437A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU57257/98A AU5725798A (en) 1997-12-29 1997-12-29 Tooth cleaning composition in tablet form
PCT/US1997/024121 WO1999033437A1 (en) 1997-12-29 1997-12-29 Tooth cleaning composition in tablet form

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/024121 WO1999033437A1 (en) 1997-12-29 1997-12-29 Tooth cleaning composition in tablet form

Publications (1)

Publication Number Publication Date
WO1999033437A1 true WO1999033437A1 (en) 1999-07-08

Family

ID=22262395

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/024121 WO1999033437A1 (en) 1997-12-29 1997-12-29 Tooth cleaning composition in tablet form

Country Status (2)

Country Link
AU (1) AU5725798A (en)
WO (1) WO1999033437A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084500A1 (en) * 2002-04-11 2003-10-16 Beiersdorf Ag Foaming cleaning emulsions containing starch
WO2007098809A1 (en) * 2006-03-03 2007-09-07 Symrise Gmbh & Co. Kg Pressed agglomerates suitable for consumption having retarded aroma release
US7279449B2 (en) 2002-04-11 2007-10-09 Beiersdorf Ag Hair shampoo containing pregelatinized, cross-linked starch derivatives
WO2007122146A1 (en) * 2006-04-26 2007-11-01 Unilever Plc Toothpaste
WO2009009953A1 (en) * 2007-07-16 2009-01-22 Waiming Wong A composition of orally gargle tablet and preparative method
WO2014085331A1 (en) * 2012-11-27 2014-06-05 Breathalyzer Equalizer, LLC Breath alcohol equalization composition
EP2296612A4 (en) * 2008-07-07 2015-03-04 Obthestvo S Ogranichennoyj Otvetstvennostjyu Wds Therapeutic and prophylactic formulation for oral care
WO2015094153A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
US20190133893A1 (en) * 2017-07-20 2019-05-09 Oscar E. Recio Saucedo Tooth Paste Gummy
US20190343737A1 (en) * 2018-05-14 2019-11-14 The Procter & Gamble Company Oral Care Compositions Comprising Fluoride Ions
WO2020172424A1 (en) * 2019-02-20 2020-08-27 One Home Brands, Inc. Stable anhydrous toothpaste concentrate formulation and method of making same
IT201900019986A1 (en) * 2019-10-29 2021-04-29 Perfetti Van Melle Spa CONFECTIONERY PRODUCT FOR INSTANT OPTICAL WHITENING OF TEETH
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431339A (en) * 1966-07-20 1969-03-04 Colgate Palmolive Co Dentifrices
US3962417A (en) * 1974-03-27 1976-06-08 Howell Charles J Dentifrice
GB2163348A (en) * 1984-08-21 1986-02-26 Dentab U K Limited Tooth cleaning tablet

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431339A (en) * 1966-07-20 1969-03-04 Colgate Palmolive Co Dentifrices
US3962417A (en) * 1974-03-27 1976-06-08 Howell Charles J Dentifrice
GB2163348A (en) * 1984-08-21 1986-02-26 Dentab U K Limited Tooth cleaning tablet

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003084500A1 (en) * 2002-04-11 2003-10-16 Beiersdorf Ag Foaming cleaning emulsions containing starch
US7279449B2 (en) 2002-04-11 2007-10-09 Beiersdorf Ag Hair shampoo containing pregelatinized, cross-linked starch derivatives
WO2007098809A1 (en) * 2006-03-03 2007-09-07 Symrise Gmbh & Co. Kg Pressed agglomerates suitable for consumption having retarded aroma release
US8524294B2 (en) 2006-03-03 2013-09-03 Symrise Ag Pressed agglomerates suitable for consumption having retarded aroma release
WO2007122146A1 (en) * 2006-04-26 2007-11-01 Unilever Plc Toothpaste
WO2009009953A1 (en) * 2007-07-16 2009-01-22 Waiming Wong A composition of orally gargle tablet and preparative method
EP2296612A4 (en) * 2008-07-07 2015-03-04 Obthestvo S Ogranichennoyj Otvetstvennostjyu Wds Therapeutic and prophylactic formulation for oral care
WO2014085331A1 (en) * 2012-11-27 2014-06-05 Breathalyzer Equalizer, LLC Breath alcohol equalization composition
US9498415B2 (en) 2012-11-27 2016-11-22 Breathalyzer Equalizer, LLC Method of countering residual mouth alcohol
WO2015094153A1 (en) * 2013-12-16 2015-06-25 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
AU2013408426B2 (en) * 2013-12-16 2017-02-02 Colgate-Palmolive Company Oral care compositions comprising calcium carbonate and talc
US20190133893A1 (en) * 2017-07-20 2019-05-09 Oscar E. Recio Saucedo Tooth Paste Gummy
US20190343737A1 (en) * 2018-05-14 2019-11-14 The Procter & Gamble Company Oral Care Compositions Comprising Fluoride Ions
AU2019269408B9 (en) * 2018-05-14 2022-09-08 The Procter & Gamble Company Oral care compositions comprising fluoride ions
US20190343733A1 (en) * 2018-05-14 2019-11-14 The Procter & Gamble Company Oral Care Compositions Comprising Metal Ions
US11944694B2 (en) 2018-05-14 2024-04-02 The Procter & Gamble Company Foaming oral care compositions
US10821056B2 (en) * 2018-05-14 2020-11-03 The Procter & Gamble Company Foaming oral care compositions
US10835455B2 (en) * 2018-05-14 2020-11-17 The Procter & Gamble Company Oral care compositions comprising metal ions
US10932996B2 (en) * 2018-05-14 2021-03-02 The Procter & Gamble Company Oral care compositions comprising fluoride ions
US11911492B2 (en) 2018-05-14 2024-02-27 The Procter & Gamble Company Oral care compositions comprising metal ions
AU2022271450B2 (en) * 2018-05-14 2023-12-14 The Procter & Gamble Company Oral care compositions comprising fluoride ions
AU2019269408B2 (en) * 2018-05-14 2022-08-18 The Procter & Gamble Company Oral care compositions comprising fluoride ions
US20190343735A1 (en) * 2018-05-14 2019-11-14 The Procter & Gamble Company Foaming Oral Care Compositions
WO2020172424A1 (en) * 2019-02-20 2020-08-27 One Home Brands, Inc. Stable anhydrous toothpaste concentrate formulation and method of making same
WO2021084401A1 (en) * 2019-10-29 2021-05-06 Perfetti Van Melle S.P.A. Confectionery product for instant optical tooth whitening
IT201900019986A1 (en) * 2019-10-29 2021-04-29 Perfetti Van Melle Spa CONFECTIONERY PRODUCT FOR INSTANT OPTICAL WHITENING OF TEETH

Also Published As

Publication number Publication date
AU5725798A (en) 1999-07-19

Similar Documents

Publication Publication Date Title
US6132702A (en) Oral care compositions comprising chlorite and methods
US6077502A (en) Oral care compositions comprising chlorite and methods
CA2321231C (en) Oral care compositions comprising chlorite and methods
RU2469701C2 (en) Oral care product and method for using it
US6238648B1 (en) Anti-caries oral care compositions and their methods of use
AU2009212335B2 (en) Compositions comprising basic amino acid and soluble carbonate salt
EP2605744B1 (en) Oral care product and methods of use and manufacture thereof
US20110014136A1 (en) Oral care product and methods of use and manufacture thereof
US5389360A (en) Oral compositions
US20060263306A1 (en) Compositions having improved substantivity
JP2005503402A (en) Oral compositions that provide enhanced overall cleansing
EP2793808B1 (en) Oral care compositions
TWI409084B (en) Compositions and methods for the treatment of xerostomia
AU730963B2 (en) Anticalculus dentifrice containing highly soluble pyrophosphate
US5688491A (en) Oral compositions
GB2317339A (en) Dentifrice composition containing a curcuminoid
WO1999033437A1 (en) Tooth cleaning composition in tablet form
KR20130018274A (en) Antimicrobial silica composites
US5496539A (en) Oral compositions
WO2018200508A1 (en) Oral care products and methods
CA2892408C (en) Oral care composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

WD Withdrawal of designations after international publication

Free format text: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, GW,HU, ID, IL, IS, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW; AP (GH, GM, KE, LS, MW, SD, SZ, UG, ZW); EA (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM); EP (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE); OA (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase